These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19664996)

  • 1. Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease.
    Weiss A; Abramowski D; Bibel M; Bodner R; Chopra V; DiFiglia M; Fox J; Kegel K; Klein C; Grueninger S; Hersch S; Housman D; Régulier E; Rosas HD; Stefani M; Zeitlin S; Bilbe G; Paganetti P
    Anal Biochem; 2009 Dec; 395(1):8-15. PubMed ID: 19664996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease model.
    Weiss KR; Kimura Y; Lee WC; Littleton JT
    Genetics; 2012 Feb; 190(2):581-600. PubMed ID: 22095086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon aging.
    Marcellin D; Abramowski D; Young D; Richter J; Weiss A; Marcel A; Maassen J; Kauffmann M; Bibel M; Shimshek DR; Faull RL; Bates GP; Kuhn RR; Van der Putten PH; Schmid P; Lotz GP
    PLoS One; 2012; 7(9):e44457. PubMed ID: 22984513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
    J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.
    Busch A; Engemann S; Lurz R; Okazawa H; Lehrach H; Wanker EE
    J Biol Chem; 2003 Oct; 278(42):41452-61. PubMed ID: 12888569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopy.
    Fodale V; Kegulian NC; Verani M; Cariulo C; Azzollini L; Petricca L; Daldin M; Boggio R; Padova A; Kuhn R; Pacifici R; Macdonald D; Schoenfeld RC; Park H; Isas JM; Langen R; Weiss A; Caricasole A
    PLoS One; 2014; 9(12):e112262. PubMed ID: 25464275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
    Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
    Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in huntington's disease.
    Baldo B; Paganetti P; Grueninger S; Marcellin D; Kaltenbach LS; Lo DC; Semmelroth M; Zivanovic A; Abramowski D; Smith D; Lotz GP; Bates GP; Weiss A
    Chem Biol; 2012 Feb; 19(2):264-75. PubMed ID: 22365609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtiter plate quantification of mutant and wild-type huntingtin normalized to cell count.
    Weiss A; Grueninger S; Abramowski D; Giorgio FP; Lopatin MM; Rosas HD; Hersch S; Paganetti P
    Anal Biochem; 2011 Mar; 410(2):304-6. PubMed ID: 21134349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification.
    Evers MM; Tran HD; Zalachoras I; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Nucleic Acid Ther; 2014 Feb; 24(1):4-12. PubMed ID: 24380395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arfaptin 2 regulates the aggregation of mutant huntingtin protein.
    Peters PJ; Ning K; Palacios F; Boshans RL; Kazantsev A; Thompson LM; Woodman B; Bates GP; D'Souza-Schorey C
    Nat Cell Biol; 2002 Mar; 4(3):240-5. PubMed ID: 11854752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of copper ion mediated Huntington's disease progression.
    Fox JH; Kama JA; Lieberman G; Chopra R; Dorsey K; Chopra V; Volitakis I; Cherny RA; Bush AI; Hersch S
    PLoS One; 2007 Mar; 2(3):e334. PubMed ID: 17396163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease.
    Li SH; Yu ZX; Li CL; Nguyen HP; Zhou YX; Deng C; Li XJ
    J Neurosci; 2003 Jul; 23(17):6956-64. PubMed ID: 12890790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.
    Wellington CL; Ellerby LM; Gutekunst CA; Rogers D; Warby S; Graham RK; Loubser O; van Raamsdonk J; Singaraja R; Yang YZ; Gafni J; Bredesen D; Hersch SM; Leavitt BR; Roy S; Nicholson DW; Hayden MR
    J Neurosci; 2002 Sep; 22(18):7862-72. PubMed ID: 12223539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.
    Kim YJ; Yi Y; Sapp E; Wang Y; Cuiffo B; Kegel KB; Qin ZH; Aronin N; DiFiglia M
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12784-9. PubMed ID: 11675509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.
    Sayer JA; Manczak M; Akileswaran L; Reddy PH; Coghlan VM
    Neuromolecular Med; 2005; 7(4):297-310. PubMed ID: 16391387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers.
    Hoffner G; Island ML; Djian P
    J Neurochem; 2005 Oct; 95(1):125-36. PubMed ID: 16181417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.